Answers are grounded in this paper and cite their sources.
The presence of hydrosalpinges is a relatively common condition in in-vitro fertilization (IVF) patients suffering from tubal disease. The prevalence of it can range from 10–13% when diagnosed by vaginal ultrasound scan (Andersen et al., 1994; Katz et al., 1996) and up to 30% when the diagnosis is based on hysterosalpingography (HSG), or direct vision via laparoscopy or in surgery (Strandell et al., 1994; Blazar et al., 1997; Murray et al., 1997). This difference is probably related to the diagnostic limitations of vaginal ultrasound in detecting small hydrosalpinges (Atri et al., 1994; de Wit et al., 1998). IVF treatment has become the main treatment for tubal infertile women with hydrosalpinges, but the effect of hydrosalpinges on IVF outcome, the mechanism(s) of this effect and, above all, the preferred method of treatment, are very controversial (Bloechle, 1999; Sharara, 1999). Not surprisingly, therefore, numerous studies, with conflicting results, have been published in recent years on these topics. Several authors investigated IVF outcome in patients with untreated hydrosalpinges, and most of them found reduced pregnancy and/or implantation rates in these patients compared with control groups (Andersen et al., 1994; Kassabji et al., 1994; Strandell et al., 1994; Vandromme et al., 1995; Fleming and Hull, 1996; Katz et al., 1996; Blazar et al., 1997). A similar picture was found following the transfer of cryopreserved–thawed embryos (Strandell et al., 1994; Akman et al., 1996). Only one group showed a (non-significant) lower pregnancy rate in the hydrosalpinges group (Sharara et al., 1996). A meta-analysis was carried out on all published reports (n = 13) and abstracts (n = 10) up to 1997 (Zeyneloglu et al., 1998), to examine the association between hydrosalpinges and IVF outcome. The authors concluded that clinical pregnancy and implantation rates were 50% lower in women who had hydrosalpinges, while the miscarriage rate was two-fold higher. They summarized the study by saying that: `although this meta-analysis suggests a strong effect of hydrosalpinges on the pregnancy rate in IVF cycles, it is far from definite. None of the studies included are prospective in design'. Indeed, since this publication, new studies have been emerged with conflicting results. Another retrospective study (Ng et al., 1997), reported similar implantation, pregnancy and clinical miscarriage rates in 43 women who had hydrosalpinges compared with 101 tubal patients without hydrosalpinges; however, the ectopic rates were higher in the former (n = 3 versus 0, P = 0.03). However, other studies (Sowter et al., 1997; Wainer et al., 1997; Murray et al., 1997; Freeman et al., 1998; de-Wit et al., 1998) have confirmed reduced pregnancy and implantation rates in women with hydrosalpinges. The decreased pregnancy rate may be correlated with the size of the hydrosalpinges because such association was not observed in women whose hydrosalpinges were not visible on ultrasound scan (de Wit et al., 1998). In spite of intensive research, there is no clear explanation for the detrimental effect of hydrosalpinges on pregnancy rate, and a few possible mechanisms have been suggested. The reflux of the hydrosalpinges fluid (HF) into the uterine cavity produces a `flushing' effect that inhibits embryo from implantation (Mansour et al., 1991; Andersen et al., 1994; 1996; Sawin et al., 1998). Sharara and McClamrock noticed that the hydrosalpinges enlarged with ovarian stimulation, causing fluid reflux into the uterine cavity that was only noted after human chorionic gonadotrophin (HCG) administration (Sharara and McClamrock, 1997). The release of cytokines, prostaglandins and other inflammatory components to the endometrium resulting in reduced endometrial receptivity. Lower concentrations of αvβ3 integrin were found in endometrial biopsies of women with hydrosalpinges (Andersen et al., 1994; Meyer et al., 1997). Several authors (Mukherjee et al., 1996; Rawe et al., 1997; Beyler et al., 1997; Nackley and Mausher, 1998) have suggested that the HF contains embryotoxic and lipophilic factors which are detrimental to the normal development of embryos. Schadeve et al. cultured mouse embryos at 0 (controls), 0.3, 0.6 and 0.9% (HF) concentrations and demonstrated significantly lower blastulation rates at each value, compared with the controls (Schadeve et al., 1997). Another report (Murray et al., 1998) showed that mouse embryos cultured in 100% human (HF) were significantly inhibited developmentally compared to control groups, but when lactate (10 mM) was added to the HF, a similar proportion of embryos reached the blastocyst stage. They speculated that no potent embryotoxic agent is present in the HF but that the inhibitory effect of HF on embryonic development is due to the absence of essential factors which can be corrected by adding energy sources. Interestingly, all the above studies investigated mouse embryos and not human embryos. Recently, two sets of authors (Granot et al., 1998; Strandell et al., 1998) have challenged the `embryotoxic theory' by claiming that HF does not adversely affect the normal development of human embryos. Moreover, Sawin et al. (1997) found that, not only is there no detrimental effect of HF, but that HF improved human trophoblast viability in vitro and enhanced the production of tropho-uteronectin and β-HCG by these cells. This improvement was dose-dependent to the concentration of HF. It may be, therefore, that HF adversely effect mouse embryos (which are more sensitive) but not human embryos (Sawin et al., 1998). The body of evidence described above, is quite convincing with regard to hydrosalpinges having a detrimental effect of on implantation and on-going pregnancy rates in IVF treatment, regardless of the exact mechanism of this effect. This conclusion led researchers to investigate methods which could give women who wish to conceive using IVF, a similar chance of success as women with tubal infertility without hydrosalpinges. But what is the preferred method in these circumstances? The answer is simply not known and the debate goes on. Recently, an excellent review (Aboulghar et al., 1998), opened the discussion with the statement that: `The management of hydrosalpinges is a difficult clinical problem'. Here, I wish to present a personal view based on the current available data and to highlight the issue from a slightly different angle. Currently, three treatment modalities for hydrosalpinges for women planning IVF are described in the literature: drug therapy, mechanical drainage of the hydrosalpinges, or a surgical approach using either salpingectomy or salpingoplasty (Table I). A high proportion of immunoglobulin (Ig)G for Chlamydia trachomatis has been found in serum samples of women with hydrosalpinges (74.6%) in proportions similar to those of tubal factor infertile women without hydrosalpinges (68.3%) (Sharara et al., 1996). All patients with elevated titres of IgG antibodies to Chlamydia were treated with doxycycline and after the antibiotic course, there was no difference in pregnancy and implantation rates between women with and without hydrosalpinges. So far, it is the only published study for drug therapy for hydrosalpinges in IVF cycles and further prospective controlled study are urgently required. Aspiration of the HF before beginning IVF stimulation produced a better ovarian response and a higher number of embryos available for transfer in 32 women who had undertaken this procedure (Aboulghar et al., 1990). However, the procedure did not improve the pregnancy rate. Two other anecdotal reports (Russel et al., 1991; Sharara et al., 1996) on the success of this procedure have been published. The former described aspiration of HF a month before IVF with successful pregnancy for a single woman, while the second was part of larger study, describing aspiration of HF at the time of oocyte retrieval in seven women undergoing 11 cycles in which five pregnancies were achieved, but unfortunately three resulted in miscarriage. Recently, two groups of researchers investigating the potential benefit of hydrosalpinges drainage on IVF outcome have conducted retrospective studies and reported conflicting results. An improved pregnancy rate was found in 18 patients who had aspiration immediately following oocyte retrieval (31%) (Van Voorhis et al., 1998) compared with a pregnancy rate of only 5% in those who have not undergone this procedure. In a larger series of 56 women whose HF was drained, no improvement in pregnancy rate was found following the drainage (Sowter et al., 1997). These results, albeit in a small number of studies, together with rapid refilling of the tubes as quickly as 2 days after the procedure (Bloechle et al., 1997), lead me to conclude that HF aspiration is not the ideal treatment. Several authors have suggested to performing salpingectomy before IVF treatment to overcome the negative effects of hydrosalpinges on pregnancy, implantation and miscarriage rates (Verhulst et al., 1994; Vandromme et al., 1995; Shelton et al., 1996; Freeman et al., 1998; Murray et al., 1998). However, all of these studies were retrospective, based on a small number of patients and gave conflicting results (Table I). Zeyneloglu et al. summarized their recent meta-analysis, which did not evaluate the effect of salpingectomy on the pregnancy rates by declaring that: `To date, there are no prospective, randomized, controlled studies investigating this effect' (Zeyneloglu et al., 1998). The single prospective controlled study published at the same time, which also included a small number of patients with hydrosalpinges (Dechaud et al., 1998) did not demonstrate a significant benefit from prophylactic salpingectomy for these patients. Moreover, salpingectomy is not a procedure without the recognized complications of operative laparoscopy and/or laparotomy in addition to the rare complications of interstitial (Raziel et al., 1989) or abdominal pregnancy (Fisch et al., 1996) following salpingectomy. Recently, a retrospective Danish study of the largest series to date of women with hydrosalpinges was published (Ejdrup Bredkjaer et al., 1999). They concluded that bilateral salpingectomy due to hydrosalpinges restores a normal delivery as well as implantation rate after IVF treatment compared with controls. In addition, they demonstrated a similar ovarian response, at least represented by average number of oocytes retrieved (9.3 compared with 9.1) in 139 women following bilateral salpingectomy and 139 tubal damaged control groups. However, their control group included patients who had previous ectopic pregnancy treated by salpingectomy or conservative surgery. They did not compare the ovarian response of patients in their study group to patients without any surgery performed on their Fallopian tubes. One study (Oehninger et al., 1989) found that neither history of pelvic adhesions nor previous tubal surgery had a significant influence on the IVF results, but a later study (Csemiczky et al., 1996) demonstrated that women with severe tubal damage (grade IV) have already reduced ovarian reserve reflected in lower response to ovarian stimulation. We have shown recently (Lass et al., 1998) that, in women who had had unilateral salpingectomy, there were fewer follicles and, consequently, fewer oocytes were retrieved from the side of operation in comparison with side with intact adnexa, without differences in pregnancy or implantation rates. The mechanism in which salpingectomy might cause reduced ovarian response is not clear but unilateral or bilateral removal of the Fallopian tubes may have a detrimental effect on the ovarian arterial supply. The medial tubal artery, which is most important for supply of blood to the tube, has its origin at the same point as the median ovarian artery. Salpingectomy, not properly performed close to the tube, may disrupt the normal blood flow to the ovary. This may have a negative impact on steroid production and further follicular development. Previously fewer ovulations on the side of microsurgical fimbriectomy (Beyth and Winston, 1981) and of surgical division of the anasthomotic blood vessels between the ovary and the fimbria (McComb and Delbeke, 1984) have been demonstrated in rabbits. We did not use Doppler flow measurements in our study (Lass et al., 1998), and to the best of my knowledge, such a study has never been published, therefore further works are required to consolidate this suspicion. Salpingectomy for women with hydrosalpinges may cause even further deterioration in the ovarian reserve. While thoroughly assessing the condition of the tube(s) which could be suitable for re-constructive surgery (Puttermans and Brosens, 1996), special attention should be paid to the ovaries themselves. For women who have a damaged or missing ovary (not an uncommon situation in women with severe pelvic disease), or women already suspected of having reduced ovarian reserve (i.e in their late 30s, early 40s, raised basal concentrations of follicle stimulating hormones (FSH), decreased basal inhibin-β concentrations), the detrimental effect of unilateral or bilateral salpingectomy may be greater than the potential benefit of this procedure. In these cases, `clamping' the proximal part of the hydrosalpinges rather than salpingectomy would be the preferred management. Summary of studies on the relation between treatment for hydrosalpinges and in-vitro fertilization (IVF). All studies are retrospective unless mention otherwise Summary of studies on the relation between treatment for hydrosalpinges and in-vitro fertilization (IVF). All studies are retrospective unless mention otherwise
No takes yet. Share an insight, caveat, or question.
Amir Lass (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: